Envoy Medical, Inc.: enters dismissal agreement with Atlas Merchant Capital

What happened The filing says Envoy Medical, Inc. entered into a Dismissal Agreement on Oct 6, 2026 with Atlas Merchant Capital SPAC Fund I LP regarding litigation in the Delaware Court of Chancery. Pursuant to the Dismissal Agreement, all of Atlas' claims will be dismissed with prejudice, there will be no further proceedings in relation to the Litigation, and neither the company nor any other defendant will be required to make a payment to Atlas.

Key details

• Date of agreement: Oct 6, 2026.
• Plaintiff: Atlas Merchant Capital SPAC Fund I LP; allegation: it was not allowed to redeem its shares of Class A Common Stock in the company's Sep 2023 business combination transaction.
• Venue: Delaware Court of Chancery.
• Outcome under the agreement: all claims dismissed with prejudice, no further proceedings, and no payment required by the company or other defendants.

Why it may matter This item was reported under Item 8.01 (other events), which covers other material events the company reports to the SEC, here the dismissal agreement and the status of the Litigation. A filing does not show why the insider traded or why the company acted.